{"id":16169,"date":"2021-05-20T06:49:40","date_gmt":"2021-05-20T13:49:40","guid":{"rendered":"https:\/\/origin-www.parsons.com\/?p=16169"},"modified":"2021-11-03T11:39:21","modified_gmt":"2021-11-03T18:39:21","slug":"atsdr-finalizes-pfas-tox-profile-may-signal-more-stringent-criteria","status":"publish","type":"post","link":"https:\/\/www.parsons.com\/2021\/05\/atsdr-finalizes-pfas-tox-profile-may-signal-more-stringent-criteria\/","title":{"rendered":"ATSDR Finalizes PFAS Tox Profile, May Signal More Stringent Criteria"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

We are actively monitoring the dynamic regulatory landscape with regard to per and polyfluorinated alkyl substances (PFAS). Technically sound and up-to-date toxicological information is critical to developing health-based regulatory criteria and risk-based solutions. We have analyzed the recently published to ATSDR Toxicological Profile for PFAS, which may signal more stringent regulatory criteria to come. <\/p>\n\n\n\n

The Agency for Toxic Substance and Disease Registry (ATSDR) recently released the final Toxicological Profile<\/a> for PFAS. The document reviewed the toxicological literature for 12 PFAS compounds and developed Minimal Risk Levels (MRLs) wherever possible. MRLs represent the daily human exposure that is likely to be without risk of noncarcinogenic effects. Following review of the toxicological data, ATSDR determined that there was sufficient data to develop MRLs for only four PFAS for intermediate (15-364 days) oral exposures:<\/p>\n\n\n\n